Overview

A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients

Status:
Completed
Trial end date:
2021-07-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effects of erenumab on central sensitization and brain networks connectivity of migraine patients
Phase:
Phase 4
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Antibodies, Monoclonal
Erenumab